CG
NKTR icon

Cutler Group’s Nektar Therapeutics NKTR Stock Holding History

Cutler Group’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,753
Closed -$4K – 4933
2022
Q3 		$4K Sell
2,753
-1,040
-27% -$61.9K ﹤0.01% 3816
2022
Q2 		$3K Sell
3,793
-880
-19% -$55.5K ﹤0.01% 4077
2022
Q1 		$18K Buy
4,673
+4,353
+1,360% +$644K ﹤0.01% 3150
2021
Q4 		$4K Buy
+320
New +$69.4K ﹤0.01% 4364
2020
Q2 		– Sell
-293
Closed -$5K – 4705
2020
Q1 		$5K Buy
+293
New +$90.6K ﹤0.01% 3093
2019
Q3 		– Sell
-127
Closed -$2K – 4495
2019
Q2 		$2K Hold
127
– – ﹤0.01% 3622
2019
Q1 		$2K Sell
127
-720
-85% -$427K ﹤0.01% 3415
2018
Q4 		$13K Sell
847
-286
-25% -$173K ﹤0.01% 2388
2018
Q3 		$266K Sell
1,133
-814
-42% -$695K 0.02% 714
2018
Q2 		$186K Buy
1,947
+594
+44% +$685K 0.01% 809
2018
Q1 		$1.09M Sell
1,353
-420
-24% -$541K 0.09% 209
2017
Q4 		$538K Sell
1,773
-127
-7% -$75.1K 0.02% 524
2017
Q3 		$45K Buy
1,900
+820
+76% +$257K ﹤0.01% 2334
2017
Q2 		$50K Sell
1,080
-593
-35% -$171K ﹤0.01% 2497
2017
Q1 		$145K Buy
+1,673
New +$376K 0.01% 1427
2016
Q4 		– Sell
-240
Closed -$2K – 7053
2016
Q3 		$2K Sell
240
-360
-60% -$92.7K ﹤0.01% 5750
2016
Q2 		$5K Buy
600
+207
+53% +$46.3K ﹤0.01% 4951
2016
Q1 		$4K Sell
393
-420
-52% -$80.7K ﹤0.01% 5064
2015
Q4 		$36K Buy
+813
New +$167K ﹤0.01% 2807

Other funds holding NKTR

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cutler Group's NKTR Position: Q1 2024 in Review

Cutler Group held its Nektar Therapeutics (NKTR) position steady in Q1 2024 at 193 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1873.

Cutler Group first reported a position in NKTR in Q4 2015 and has held it in 32 quarters since. The position peaked at $1.41M in Q1 2018. 124 funds tracked by Wall St. Rank hold NKTR as of Q1 2024.

  • Cutler Group held 193 shares of Nektar Therapeutics worth $2K as of Q1 2024.
  • Cutler Group left its Nektar Therapeutics share count unchanged in Q1 2024.
  • Nektar Therapeutics made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1873 holding.
  • Cutler Group first reported a position in Nektar Therapeutics in Q4 2015 and has held it in 32 quarters since.
  • Cutler Group's Nektar Therapeutics position peaked at $1.41M in Q1 2018.
  • 124 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.